Abstract:The gold standard for treating peripheral nerve injuries that have large nerve gaps where the nerves cannot be directly sutured back together because it creates tension on the nerve, is to incorporate an autologous nerve graft. However, even with the incorporation of a nerve graft, generally patients only regain a small portion of function in limbs affected by the injury. Although, there has been some promising results using growth factors to induce more axon growth through the nerve graft, many of these previous therapies are limited in their ability to release growth factors in a sustained manner and tailor them to a desired time frame. The ideal drug delivery platform would deliver growth factors at therapeutic levels for enough time to grow axons the entire length of the nerve graft. We hypothesized that mineral coated microparticles (MCMs) would bind, stabilize and release biologically active glial cell-derived neurotrophic factor (GDNF) and nerve growth factor (NGF) in a sustained manner. Therefore, the objective of this study was to test the ability of MCMs releasing growth factors at the distal end of a 10 mm sciatic nerve graft, to induce axon growth through the nerve graft and restore hind limb function. After sciatic nerve grafting in Lewis rats, the hind limb function was tested weekly by measuring the angle of the ankle at toe lift-off while walking down a track. Twelve weeks after grafting, the grafts were harvested and myelinated axons were analyzed proximal to the graft, in the center of the graft, and distal to the graft. Under physiological conditions <i>in vitro</i>, the MCMs delivered a burst release of NGF and GDNF for 3 days followed by a sustained release for at least 22 days. <i>In vivo</i>, MCMs releasing NGF and GDNF at the distal end of sciatic nerve grafts resulted in significantly more myelinated axons extending distal to the graft when compared to rats that received nerve grafts without growth factor treatment. The rats with nerve grafts incorporated with MCMs releasing NGF and GDNF also showed significant improvement in hind limb function starting at 7 weeks postoperatively and continuing through 12 weeks postoperatively when compared to rats that received nerve grafts without growth factor treatment. In conclusion, MCMs released biologically active NGF and GDNF in a sustained manner, which significantly enhanced axon growth resulting in a significant improvement of hind limb function in rats. The animal experiments were approved by University of Wisconsin-Madison Animal Care and Use Committee (ACUC, protocol# M5958) on January 3, 2018.

A Sequential Delivery System Employing the Synergism of EPO and NGF Promotes Sciatic Nerve Repair.

Localized and Sustained Delivery of Erythropoietin from Plga Microspheres Promotes Functional Recovery and Nerve Regeneration in Peripheral Nerve Injury

Nanoparticle Mediated Controlled Delivery of Dual Growth Factors

Dual-delivery of VEGF and NGF by Emulsion Electrospun Nanofibrous Scaffold for Peripheral Nerve Regeneration.

Nerve growth factor-basic fibroblast growth factor poly-lactide co-glycolid sustained-release microspheres and the small gap sleeve bridging technique to repair peripheral nerve injury

Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair.

A novel hydrogel-based combination therapy for effective neuroregeneration after spinal cord injury

Enhancement of Sciatic Nerve Regeneration with Dual Delivery of Vascular Endothelial Growth Factor and Nerve Growth Factor Genes

A Novel Nerve Guidance Conduit with Sustained Release of NGF Enhances Sciatic Nerve Regeneration

Improved Peripheral Nerve Regeneration with Sustained Release Nerve Growth Factor Microspheres in Small Gap Tubulization.

Control-released Basic Fibroblast Growth Factor-Loaded Poly-Lactic-co-glycolic Acid Microspheres Promote Sciatic Nerve Regeneration in Rats.

Small-Molecule SB216763-Loaded Microspheres Repair Peripheral Nerve Injury in Small Gap Tubulization

Development of Dual Neurotrophins-Encapsulated Electrospun Nanofibrous Scaffolds for Peripheral Nerve Regeneration

Single Injection of a Novel Nerve Growth Factor Coacervate Improves Structural and Functional Regeneration after Sciatic Nerve Injury in Adult Rats.

Sustainable Release of Nerve Growth Factor for Peripheral Nerve Regeneration Using Nerve Conduits Laden with Bioconjugated Hyaluronic Acid-Chitosan Hydrogel

Functional recovery after peripheral nerve injury via sustained growth factor delivery from mineral-coated microparticles

Gelatin Nanostructured Lipid Carriers Incorporating Nerve Growth Factor Inhibit Endoplasmic Reticulum Stress-Induced Apoptosis and Improve Recovery in Spinal Cord Injury

Growth factors: Bioactive macromolecular drugs for peripheral nerve injury treatment – Molecular mechanisms and delivery platforms

Preparation and Characterization of Poly Lactic Acid/Graphene Oxide/Nerve Growth Factor Scaffold with Electrical Stimulation for Peripheral Nerve Regeneration in vitro

Repairing Sciatic Nerve Injury with an EPO-loaded Nerve Conduit and Sandwiched-in Strategy of Transplanting Mesenchymal Stem Cells.

Synergistic Effects of Dual-Presenting VEGF- and BDNF-mimetic Peptide Epitopes from Self-Assembling Peptide Hydrogels on Peripheral Nerve Regeneration